PT  - JOURNAL ARTICLE
AU  - Altaf, Mohammed
AU  - Irfan, Md Azhar
AU  - Naheed, Nazneen
AU  - Aleemuddin, NM
TI  - Phenotypic and functional characterisation of circulating cytomegalovirus-specific T cells in healthy virus carriers and lung transplant candidates
AID  - 10.1101/2021.06.04.21256785
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.04.21256785
4099  - http://medrxiv.org/content/early/2021/06/22/2021.06.04.21256785.short
4100  - http://medrxiv.org/content/early/2021/06/22/2021.06.04.21256785.full
AB  - This manuscript has been withdrawn by the authors as it was submitted and made public without appropriate approval. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from the Australian National Health and Medical Research Council (APP1132519; APP1062074).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This prospective cohort research was performed according to the principles of the Declaration of Helsinki. Ethics approval to undertake the research involving healthy volunteers was obtained from QIMR Berghofer Human Research Ethics Committee. Ethics approval to undertake the research involving lung transplant candidates was obtained from both The Prince Charles Hospital Human Research Ethics Committee and QIMR Berghofer Medical Research Institute Human Research Ethics Committee. Written informed consent was obtained from all participants prior to inclusion in the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available on request to corresponding author by email.